SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
COLL

Collegium Pharmaceutical, Inc (COLL)

NASDAQ: COLL · Real-Time Price · USD
Healthcare · Drug Manufacturers - Specialty & Generic
$25.43+$0.11 (+0.43%)
 
Market cap
$790M
Insider Score
Analyst consensus
Market Cap$790.25M-44.7%
Revenue (ttm)$815.19M
Net Income$38.17M
EPS$1.09
Shares Out31.08M
PE Ratio23.33
Forward PE3.59
Dividendn/a
Ex-Dividend Daten/a
Volume494,890
Open$25.68
Previous Close$25.32
Day's Range$25.04 - $25.68
52-Week Range$21.43 - $50.79
Beta0.73
AnalystsStrong Buy
Price Target$44.00(+73.02%)
Earnings DateNov 5, 2026

About COLL

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an extended treatment period; Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone for the management of pain severe enough to require daily; Nucynta ER and Nucynta IR, which are extended-release and immediate-release oral formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. Collegium Pharmaceutical, Inc. was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. The company was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.

Address
100 Technology Center Drive, Stoughton, MA, 02072, United States
Market Cap
790 million
Employees
423
Industrial Classification
Drug Manufacturers - Specialty & Generic
1 Day
+0.43%
5 Days
+2.91%
1 Month
+9.66%
6 Months
-24.43%
1 Year
-44.69%

$COLL stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in COLL holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by COLL's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

COLL Estimated quarterly lobbying spending

Source: U.S. Senate LDA

COLL Revenue by Segment

$216.34MTotal
Belbuca$57.72M26.68%
Jornay PM$51.86M23.97%
Xtampza ER$45.82M21.18%
Azstarys$26.52M12.26%
Nucynta IR$16.72M7.73%
Nucynta ER$9.91M4.58%
Nucynta ER AG$3.88M1.79%
Symproic$3.62M1.68%
Nucynta IR AG$279.00K0.13%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New COLL patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to COLL from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from COLL’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
No data yet
—
Analyst Ratings
62% of score
99
News & Sentiment
38% of score
72

News check: Oppenheimer initiated COLL at Outperform with $50 PT and praised durable cash flow; analyst upgrades outweigh generic opinion pieces.

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

SURISimplify Propel Opportunities ETF3.01%
PJPInvesco Pharmaceuticals ETF2.72%
PBEInvesco Biotechnology & Genome ETF2.42%
XPHState Street SPDR S&P Pharmaceuticals ETF2.08%
SIXSETC 6 Meridian Small Cap Equity ETF1.18%
MGMTBallast Small/Mid Cap ETF1.09%
RZGInvesco S&P SmallCap 600 Revenue ETF0.63%
DSMCDistillate Small/Mid Cash Flow ETF0.59%
HAPSHarbor Human Capital Factor US Small Cap ETF0.56%
SFLOVictoryShares Small Cap Free Cash Flow ETF0.51%
SCOWPacer Funds Trust - Pacer S&P SmallCap 600 Quality FCF Aristocrats ETF0.43%
PSCHInvesco S&P SmallCap Health Care ETF0.43%

Weight is the stock’s share of each fund’s holdings.